| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/MT.2009.265 |
| P8608 | Fatcat ID | release_eqljahrlkvbjxe2cdzabhqps44 |
| P932 | PMC publication ID | 2839314 |
| P698 | PubMed publication ID | 19904233 |
| P5875 | ResearchGate publication ID | 38080828 |
| P50 | author | Grant McFadden | Q88652661 |
| P2093 | author name string | John Olson | |
| Dongqin Zhu | |||
| Darnell T Josiah | |||
| Fernanda Dreher | |||
| Hannah Caldas | |||
| P2860 | cites work | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 |
| Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 | ||
| Adventures with poxviruses of vertebrates | Q30846908 | ||
| Brain tumor survival: results from the National Cancer Data Base | Q31932199 | ||
| Brain and other central nervous system tumors: rates, trends, and epidemiology. | Q34221574 | ||
| Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. | Q34574890 | ||
| Immune responses to myxoma virus | Q34702782 | ||
| Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas | Q35216380 | ||
| Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas | Q35610296 | ||
| Factors influencing survival in high-grade gliomas | Q35650045 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Oncolytic viruses for the treatment of cancer: current strategies and clinical trials. | Q35902523 | ||
| Oncolytic viral therapies - the clinical experience | Q36318202 | ||
| Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer | Q36723147 | ||
| Oncolytic viruses in cancer therapy | Q36769180 | ||
| Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies | Q36786235 | ||
| Cell carriers for oncolytic viruses: Fed Ex for cancer therapy | Q37582184 | ||
| Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments | Q40139570 | ||
| Reovirus as an oncolytic agent against experimental human malignant gliomas | Q43646730 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Search and destroy: recent research exploits adult stem cells' attraction to cancer | Q48966593 | ||
| Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents | Q58828469 | ||
| Multilineage cells from adipose tissue as gene delivery vehicles | Q64378045 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| P433 | issue | 2 | |
| P921 | main subject | glioblastoma | Q282142 |
| oncolytic virus | Q1560099 | ||
| P304 | page(s) | 377-385 | |
| P577 | publication date | 2009-11-10 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma | |
| P478 | volume | 18 |
| Q38664590 | A discussion on adult mesenchymal stem cells for drug delivery: pros and cons |
| Q26849284 | Adipose tissue stem cells: the great WAT hope |
| Q58999088 | Adipose-Derived Stem Cells in Tissue Regeneration: A Review |
| Q96685704 | Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas |
| Q38227489 | Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy |
| Q38924531 | Cell carriers for oncolytic viruses: current challenges and future directions |
| Q44293731 | Comparative phenotypic and molecular characterization of porcine mesenchymal stem cells from different sources for translational studies in a large animal model |
| Q36072832 | Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells |
| Q35616420 | Competitive electroporation formulation for cell therapy |
| Q37833578 | Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? |
| Q35029126 | Directing systemic oncolytic viral delivery to tumors via carrier cells |
| Q38063945 | Drug delivery systems: Advanced technologies potentially applicable in personalized treatments |
| Q39025610 | Electroporation formulation for cell therapy |
| Q42412637 | Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer |
| Q38696750 | Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer |
| Q35964770 | Human adipose-derived stem cells impair natural killer cell function and exhibit low susceptibility to natural killer-mediated lysis |
| Q35626536 | IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications |
| Q35456178 | Identification and characterization of unique tumoricidal genes in rat umbilical cord matrix stem cells |
| Q38348844 | Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No? |
| Q35110929 | Lentivirus vector-mediated gene transduction of CNGRC peptide in rat adipose stem cells |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q38715077 | Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas |
| Q35553117 | Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy |
| Q98292352 | Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma |
| Q91558752 | Novel Therapeutic Approach Using Drug-loaded Adipose-derived Stem Cells for Pancreatic Cancer |
| Q35234349 | Oncolytic Poxviruses |
| Q89769530 | Oncolytic Viruses and the Immune System: The Dynamic Duo |
| Q37126088 | Oncolytic myxoma virus: the path to clinic |
| Q28078939 | Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer |
| Q92099101 | Oncolytic viruses: overcoming translational challenges |
| Q37865172 | Recent advances in oncolytic virus design |
| Q90361854 | Stem cells: a promising candidate to treat neurological disorders |
| Q55085319 | Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. |
| Q40786098 | The adipose-derived stem cell: looking back and looking ahead |
| Q26852597 | The impact of non-electrical factors on electrical gene transfer |
| Q38730790 | Use of genetically engineered stem cells for glioma therapy |
| Q26765364 | shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy |
Search more.